Recent Research
Sales Force Effectiveness Report Sample
Q1. How important do you feel the following characteristics are for a pharmaceutical representative? (rated on a scale of 1 to 10)
|
Presentation
a) Courtesy -----------------------------------------------> b) Dress c) Appearance d) Punctuality e) Providing me with gifts f) Providing me with a meal Knowledge g) Knowledge of product h) Knowledge of NHS i) Knowledge of physiology & pathology j) Knowledge of health care provision k) Knowledge of practice based commissioning l) Knowledge of what’s happening in other parts of the NHS m) Knowledge of clinical practices in my locality Attitude n) Understanding my role o) Leaving information for me in hard copy p) Providing information for me electronically q) Making a presentation using printed material r) Making a presentation using an electronic aide s) Being quick about the process of giving me information t) Providing the information at my pace u) Listening to what I have to say |
 |
Q2. Thinking about the last few pharmaceutical representatives that you have seen please rate them for the following characteristics (rated on a scale of 1 to 10)
|
Presentation
a) Courtesy -----------------------------------------------> b) Dress c) Appearance d) Punctuality e) Providing me with gifts f) Providing me with a meal Knowledge g) Knowledge of product h) Knowledge of NHS i) Knowledge of physiology & pathology j) Knowledge of health care provision k) Knowledge of practice based commissioning l) Knowledge of what’s happening in other parts of the NHS m) Knowledge of clinical practices in my locality Attitude n) Understanding my role o) Leaving information for me in hard copy p) Providing information for me electronically q) Making a presentation using printed material r) Making a presentation using an electronic aide s) Being quick about the process of giving me information t) Providing the information at my pace u) Listening to what I have to say |
CLICK HERE To open chart showing Company Comparison Example Scores for Courtesy  |
Q3. What changes could have been made by the pharmaceutical companies to improve your interaction with the representatives? (open text responses)
Sample Response:
“Could have made it relevant – discussed drug commenced in secondary care only”
Q4. What changes could have been made by the representative to improve your interaction with them? (open text responses)
Sample Response:
“Listen to my needs rather than get out their detail aids and settle in for hours.”
Q5. Do you think pharmaceutical companies should: (select from 3 options)
Increase the number of visits representatives make to you
Decrease the number of visits representatives make to you
Make no change to the number of visits representatives make to you
| N | % | |
| Increase the number of visits representatives make to you | xxx | xxx |
| Decrease the number of visits representatives make to you | xxx | xxx |
| Make no change to the number of visits representatives make to you | xxx | xxx |
Q6. Why do you think pharmaceutical companies should “make the changes you requested in Q5” ?
(open text responses)
Sample Response:
“On average see 2-4 reps per month and this I think is quite adequate.”
Q7. From which of the following pharmaceutical companies have you seen a representative in the last three months? (select from 44 companies)
| Company Name | ||
| Abbott | ||
| Actelion | ||
| Allergan | ||
| Altana Nycomed | ||
| Astellas | ||
| AstraZeneca | ||
| Bayer Schering | ||
| Boehringer Ingelheim | ||
| Bristol-Myers Squibb | ||
| Cephalon | ||
| Daichi Sankyo | ||
| Eisai | ||
| Eli Lilly | ||
| Galen | ||
| GlaxoSmithKline (GSK) | ||
| Grunenthal | ||
| Innovex | ||
| Janssen-Cilag | ||
| Leo | ||
| Lundbeck | ||
| Merck Serono | ||
| Merck Sharp & Dohme (MSD) | ||
| Napp | ||
| Norgine | ||
| Novartis | ||
| Novo Nordisk | ||
| Organon | ||
| Pfizer | ||
| Proctor & Gamble | ||
| ProStrakan | ||
| Reckitt Benkiser | ||
| Recordati | ||
| Roche | ||
| Sanofi Aventis | ||
| Schering-Plough | ||
| Schwarz | ||
| Servier | ||
| Shire | ||
| Solvay | ||
| Stiefel | ||
| Takeda | ||
| Teva Pharmaceutical Industries | ||
| UCB | ||
| Wyeth |
Q8. Which of the following pharmaceutical companies, if any, have you elected not to see the representative? (select from 44 companies)
| Company Name | ||
| Abbott | ||
| Actelion | ||
| Allergan | ||
| Altana Nycomed | ||
| Astellas | ||
| AstraZeneca | ||
| Bayer Schering | ||
| Boehringer Ingelheim | ||
| Bristol-Myers Squibb | ||
| Cephalon | ||
| Daichi Sankyo | ||
| Eisai | ||
| Eli Lilly | ||
| Galen | ||
| GlaxoSmithKline (GSK) | ||
| Grunenthal | ||
| Innovex | ||
| Janssen-Cilag | ||
| Leo | ||
| Lundbeck | ||
| Merck Serono | ||
| Merck Sharp & Dohme (MSD) | ||
| Napp | ||
| Norgine | ||
| Novartis | ||
| Novo Nordisk | ||
| Organon | ||
| Pfizer | ||
| Proctor & Gamble | ||
| ProStrakan | ||
| Reckitt Benkiser | ||
| Recordati | ||
| Roche | ||
| Sanofi Aventis | ||
| Schering-Plough | ||
| Schwarz | ||
| Servier | ||
| Shire | ||
| Solvay | ||
| Stiefel | ||
| Takeda | ||
| Teva Pharmaceutical Industries | ||
| UCB | ||
| Wyeth |
Return to Sales Force Effectiveness Report Sample
Return to Recent Research
